Purpose
to define skeletal muscle dysregulation and provide a rationale for using well-characterized adrenergic drugs to improve neonatal muscle growth and metabolism.
Grantee
Division
Global Growth & Opportunity,
Global Health
Date
NOVEMBER 2012
Region served
GLOBAL
Committed amount
$925,661
Grant topic
Discovery and Translational Sciences,
Nutrition
Duration (months)
54
Grantee location
Tucson, Arizona, United States
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.